Press Releases
Home › Press Releases
The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.
All press releases and other information listed below were, to the best of Angiotech's knowledge, timely and accurate when issued. However, the passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. Angiotech does not assume the obligation to update this information. All viewers should carefully check the dates of issuance of the material contained in the Angiotech site.
2009
- November 9Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Third Quarter Ended September 30, 2009
- October 23Angiotech Pharmaceuticals Announces Commercial Launch of the Tan EndoGlide™ Endothelium Insertion System in the United States at the American Academy of Ophthalmology Annual Meeting
- October 19Angiotech Pharmaceuticals Provides Update on Bio-Seal™ 510(K) Submission
- October 9Notice of Conference Call and Webcast: Third Quarter 2009 Financial Results
- September 22Angiotech Pharmaceuticals Announces TAXUS® Liberte® Stent Continues to Demonstrate Significant Improvements Over TAXUS® Express® Stent in Small Vessels and Long Lesions
- September 2Angiotech's Corporate Partner, Bost Scientific, Reports Two-Year SYNTAX Data Showing Comparable Safety Outcomes for Complex Patients Treated with TAXUS® Express® Stents and Bypass Surgery
- August 20Angiotech Pharmaceuticals Announces the Commercial Launch of the Option™ Inferior Vena Cava Filter in the United States
- August 13Angiotech Receives Approval for Quill™ SRS PDO, MONODERM™, Polypropylene and Nylon Product Lines for Sale in Brazil
- August 11Angiotech's Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver® PTX® Stent
- August 6Correction: Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Second Quarter Ended June 30, 2009
- August 4Angiotech Pharmaceuticals Announces Launch of Quill™ SRS Product Codes For Laparoscopic Gynecology Procedures
- July 23Angiotech Pharmaceuticals, Inc. Announces Filing of Shelf Registration Statement
- July 16Angiotech Pharmaceuticals Announces FDA Approval of TAXUS® Liberte® Long Stent
- July 6Notice of Conference Call and Webcast: Second Quarter 2009 Financial Results
- June 8Angiotech Pharmaceuticals Announces FDA 510(K) Clearance of the Option™ Inferior Vena Cava Filter
- June 3Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
- May 27Angiotech Pharmaceuticals Announces FDA Approval of Next-Generation TAXUS® Liberté® Atom™ Stent System
- May 20Syntax Analysis Finds Treatment With Taxus® Express2® Stent System More Cost Effective Than Bypass Surgery In Patients With Complex Coronary Artery Disease
- May 19Syntax Substudy Shows Positive Outcomes for Left Main Patients Treated with TAXUS® Express2® Stent System
- May 19Angiotech's Corporate Partner, Boston Scientific, Announces Launch of Third-Generation TAXUS® Element™ Stent
- May 19Angiotech Launches E-Commerce Website that Allows Customers to Order Quill™ SRS Product Line
- May 11Angiotech and Boston Scientific Welcome Journal Article Noting Important Differences Between Drug-Eluting Stent Brands
- April 30Correction: Angiotech Pharmaceuticals, Inc. Announces Financial Results for the First Quarter Ended March 31, 2009
- April 24Angiotech Announces Date of Annual General Meeting of Shareholders
- April 16Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast: First Quarter 2009 Financial Results
- April 14New Study Shows that Zilver® PTX™ Effectively Treats Blockages in Critical Thigh Artery
- March 31Angiotech Pharmaceuticals Inc. Announces License Agreement with Baxter International Inc.
- March 9Angiotech Announces Positive Results from Bio-Seal™ Clinical Study
- March 5Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 31, 2008
- March 2Angiotech Pharmaceuticals, Inc. Announces New Senior Secured Term Loan and Credit Facilities
- February 26Correction: Angiotech Receives Approval for Quill™ SRS PDO, MONODERM™ and Nylon Product Lines For Sale in Canada
- February 24Angiotech Pharmaceuticals Announces Time Change of Conference Call and Webcast
- February 17Notice of Conference Call and Webcast: Fourth Quarter and Year End 2008 Financial Results
- February 5Angiotech's Corporate Partner, Boston Scientific, Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
- January 29Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Approval for TAXUS® Liberté® Drug-Eluting Stent System
News
Quick Links
© Copyright 2010 Angiotech. All Rights Reserved.